Stefanie Heilmann-Heimbach Selected Research

Epithelial Cell Adhesion Molecule

1/2022

Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefanie Heilmann-Heimbach Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2017
5	Genetic Risk Score 11/2023 - 01/2016
5	Alopecia (Baldness) 01/2022 - 04/2016
3	Inflammation (Inflammations) 12/2023 - 10/2017
3	Dementia (Dementias) 11/2023 - 01/2019
3	Cognitive Dysfunction 01/2023 - 01/2016
3	Schizophrenia (Dementia Praecox) 11/2022 - 10/2017
3	Neoplasms (Cancer) 01/2022 - 01/2018
2	Angioedema 01/2024 - 01/2022
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2023 - 11/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2018
2	Alcoholism (Alcohol Abuse) 10/2018 - 01/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2024
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	COVID-19 11/2022
1	Respiratory Insufficiency (Respiratory Failure) 11/2022
1	Hereditary Angioedemas 01/2022
1	Tics (Tic) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Emergence Delirium 10/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2020
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Diabetes Mellitus 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Congenital Diaphragmatic Hernias 07/2018
1	Pulmonary Hypertension 07/2018
1	Lung Diseases (Lung Disease) 07/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Multiple Sclerosis 01/2018
1	Mental Disorders (Mental Disorder) 10/2017
1	Rare Diseases (Rare Disease) 01/2017

Drug/Important Bio-Agent (IBA)

6	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2016
3	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 11/2023 - 11/2022
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2018
3	AndrogensIBA 01/2022 - 04/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024 - 01/2022
2	BradykininIBA 01/2024 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2017
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 07/2018 - 01/2017
2	ApolipoproteinsIBA 05/2018 - 01/2016
1	LithiumIBA 12/2023
1	Immunologic Factors (Immunomodulators)IBA 12/2023
1	Amyloid beta-PeptidesIBA 11/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 10/2021
1	sharpinIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	LipidsIBA 01/2019
1	5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2018
1	CytokinesIBA 07/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018
1	Ginkgo biloba extract (Rokan)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Factor VII (Proconvertin)IBA 10/2017
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 10/2017
1	Protein SIBA 10/2017
1	von Willebrand FactorIBA 10/2017
1	Blood Proteins (Serum Proteins)IBA 10/2017
1	Chromogranin AIBA 10/2017
1	Cystatin CIBA 10/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2017
1	Interferon-gamma (Interferon, gamma)IBA 10/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2016

Therapy/Procedure

1	Therapeutics 01/2022
1	Transplantation 10/2020